Bulletin from the extraordinary general meeting in Klaria Pharma Holding AB (publ)
At the extraordinary general meeting held in Klaria Pharma Holding AB (publ) today on 30 November 2022, it was resolved to approve the board of directors’ resolution on issuance of shares with preferential rights for the shareholders (in accordance with the proposal presented in the notice to attend the meeting kept available at the company’s website www.klaria.com).The extraordinary general meeting resolved to approve the board of directors’ resolution made on 14 November 2022 on issuance of shares with preferential rights for the shareholders. As announced on 14 November 2022, the terms